Insights
Leadership
How will new entrants drive market change?
Alan Lotvin and David Feinberg share some of the work taking place to use insights gained from the large, growing databases of consumer behavior.
Read More
Curative Therapies
Vinod Khosla on network medicine: The role of primary care physicians will become more important
As AI provides better tools for diagnosis, Khosla believes the role of specialists and primary care doctors will change
Read More
Leadership
Get out of the health care bubble to hear other leaders’ experiences
Leaders share the decisions that drove their careers and often pushed them beyond their comfort zone
Read More
Leadership
Eric Schmidt: Until AI's "unknown errors" can be explained, the systems will remain advisory
AI is making remarkable strides and presenting challenges in the lab.
Read More
Leadership
Adam Boehler: CMS will provide the right incentives for risk-based models to succeed
At the Health Evolution Summit, a preview of the changes that CMS is developing.
Read More
Leadership
To succeed in a risk-based environment, CEOs need to be smart recruiters
Solving today's complex challenges requires new approaches to recruitment.
Read More
Social Determinants
Coordinating community resources is key to changing social determinants
The social determinants of health—factors like access (or lack of it) to food, shelter and transportation, exposure to environmental contaminants, and risks from domestic or community violence—account for up to 80 percent of a person’s state of health.
Read More
Social Determinants
Social determinants lesson #1: Providers must listen
When Mandy Cohen, MD, Secretary of the North Carolina Department of Health and Human Services, was a young resident, she saw a 24-year-old patient, commercially insured, who was losing weight and even losing her hair.
Read More
Curative Therapies
Pricing a cure? Experts debate how to ID the true value of 7-figure drugs
Who decides what a drug is worth? This question is central to determining whether and how our healthcare system pays for a new generation of five-, six-, and even seven-figure drugs that promise cures, or at least long-term remissions, for deadly or debilitating diseases.
Read More
Curative Therapies
“Drug mortgages” may be the solution to fund million-dollar cures
Buying a six-figure therapy may require individuals to pay over time.
Read More
